The shot is personalized to each patient, targeting their specific cancer. A UK man has become one of the first to receive an experimental mRNA vaccine designed to prevent recurrence of melanoma skin cancer. Steve Young, a 52-year-old musician, had a stage II melanoma removed previously, and said the shot is his “best chance” at stopping the cancer coming back. “I feel … [Read more...] about World-First mRNA Vaccine For Skin Cancer Commences Landmark Phase 3 Trial